[ Epic Sciences raises $40M in Series D ]

Epic Sciences has raised $40 million in Series D funding.

Founded in 2008, Epic Sciences  is a privately held diagnostics company committed to improving cancer management by providing easily accessible and real-time biopsy material to guide personalized medicine.

The fund will go to accelerate clinical studies and enhance the Epic Sciences’s  technology.

Funding  Series D
Founded  2008
Country  USA
City  La Jolla, California
Founder / CEO  Murali K. Prahalad
Deal Size  $40M
Investors  Viventures
 Hermed Capital
 Altos Capital Partners
 Domain Associates
 Genomic Health
 Pagoda Investment
 Reach Tone
 RMI Partners
 Sabby Capital
Previous Investors  Venrock
 Silicon Valley Bank
 RMI Partners
 Arcus Ventures
 Pfizer Venture Investments
 Domain Associates
 Roche Venture Fund

[adyen action=”checkout_button”]